What if the next breakthrough in surgical robotics isn't happening in the operating room, but inside the blood vessels?
In this episode, David Fischel, Chairman and CEO of Stereotaxis, shares how the company is pioneering robotic endovascular surgery through an integrated platform of robotics, proprietary catheters, and digital technologies. He explains why successful surgical robotics requires an entire ecosystem that seamlessly connects devices, software, imaging, and physician workflows. David also reflects on Stereotaxis' transformation through nearly a decade of investment in research and development, regulatory milestones, and commercialization. Together, we discuss how intelligent robotics could make complex cardiovascular and neurovascular procedures safer, more precise, and more accessible in the years ahead.
Tune in to hear how Stereotaxis is redefining robotic intervention, why ecosystem thinking is critical for healthcare innovation, and what the future of intelligent surgery could look like for physicians and patients!
Resources: